These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 5067775)

  • 1. Diphenylhydantoin suspension hazard.
    JAMA; 1972 Jul; 221(1):89. PubMed ID: 5067775
    [No Abstract]   [Full Text] [Related]  

  • 2. Toxic reaction to improperly administered phenytoin suspension.
    Leventhal LJ; Gould J
    Arch Intern Med; 1987 Dec; 147(12):2221. PubMed ID: 3689080
    [No Abstract]   [Full Text] [Related]  

  • 3. Diphenylhydantoin risks in children.
    Lagos JC
    JAMA; 1972 May; 220(5):726. PubMed ID: 5067155
    [No Abstract]   [Full Text] [Related]  

  • 4. The formulation of an oral suspension of diphenylhydantoin.
    WIEGAND CF; HUYCK CL
    Am J Pharm Sci Support Public Health; 1956 Jan; 128(1):24-9. PubMed ID: 13302406
    [No Abstract]   [Full Text] [Related]  

  • 5. [Multiple myeloma associated with phenytoin (diphenylhydantoin) therapy].
    Kanoh T; Dobashi H; Inada T
    Rinsho Ketsueki; 1996 Mar; 37(3):239-43. PubMed ID: 8727349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Permanent cerebellar degeneration secondary to diphenylhydantoin (author's transl)].
    Rosich Pla A
    Med Clin (Barc); 1980 Nov; 75(9):387-90. PubMed ID: 7464334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Histopathological study on diphenylhydantoin gingival hyperplasia in rats, especially the role of gingival inflammation in diphenylhydantoin gingival hyperplasia].
    Watanabe H
    Nihon Shishubyo Gakkai Kaishi; 1982 Sep; 24(3):385-408. PubMed ID: 6962259
    [No Abstract]   [Full Text] [Related]  

  • 8. [Phenytoin (5,5-diphenylhydantoin) hypersensitivity presenting a clinical picture of scarlatiniform erythroderma].
    Fischbeck R; Zucker G
    Dtsch Gesundheitsw; 1966 Jul; 21(27):1273-7. PubMed ID: 4224585
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics of three formulations of diphenylhydantoin in the dog.
    Overduin LM; van Gogh H; Mol JA; van Nes JJ
    Res Vet Sci; 1989 Mar; 46(2):271-3. PubMed ID: 2704892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diphenylhydantoin-induced hypogammaglobulinemia in a patient infected with human immunodeficiency virus.
    Britigan BE
    Am J Med; 1991 Apr; 90(4):524-7. PubMed ID: 2012095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diphenylhydantoin (phenytoin)--a potent psychopharmaceutic drug?].
    Lund K
    Tidsskr Nor Laegeforen; 1968 Nov; 88(22):2137-9. PubMed ID: 5725143
    [No Abstract]   [Full Text] [Related]  

  • 12. Diphenylhydantoin (Dilantin) in cardiac arrhythmias.
    Med Lett Drugs Ther; 1967 Aug; 9(16):64. PubMed ID: 6034880
    [No Abstract]   [Full Text] [Related]  

  • 13. Diphenylhydantoin toxicity.
    Helfant RH; Scherlag BJ; Damato AN
    JAMA; 1967 Sep; 201(11):894. PubMed ID: 6071915
    [No Abstract]   [Full Text] [Related]  

  • 14. Diphenylhydantoin and acne.
    Jenkins RB; Ratner AC
    N Engl J Med; 1972 Jul; 287(3):148. PubMed ID: 4260678
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hyperplasia caused by diphenylhydantoin in patients with and without teeth (I)].
    Dreyer WP; Thomas CJ
    Med Hyg (Geneve); 1982 Mar; 40(1460):835-7. PubMed ID: 6953309
    [No Abstract]   [Full Text] [Related]  

  • 16. Diphenylhydantoin: inaccuracies in national magazines.
    Livingston S
    Am J Psychiatry; 1968 Jul; 125(1):115-6. PubMed ID: 5657365
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter: Diphenylhydantoin and blood dyscrasias.
    Livingston S; Pauli LL
    JAMA; 1974 Oct; 230(2):211-2. PubMed ID: 4479170
    [No Abstract]   [Full Text] [Related]  

  • 18. [Diphenylhydantoin and abnormalities of visual pathways].
    Bartolomé E; Domínguez R; González S; Blanc C; Chamoles N; Delamonica E
    Medicina (B Aires); 1990; 50(3):277-9. PubMed ID: 2130220
    [No Abstract]   [Full Text] [Related]  

  • 19. Phenytoin (diphenylhydantoin).
    Med Lett Drugs Ther; 1976 Feb; 18(5):23-4. PubMed ID: 1256358
    [No Abstract]   [Full Text] [Related]  

  • 20. The value of serum diphenylhydantoin (phenytoin) levels in the management of epilepsy.
    Reynolds EH
    Proc R Soc Med; 1975 Feb; 68(2):102-4. PubMed ID: 1166035
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.